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ABSTRACT
Initiation of DNA replication involves the ordered
assembly of the multi-protein pre-replicative com-
plex (pre-RC) during G1 phase. Previously, DNA
topoisomerase II (topo II) was shown to associate
with the DNA replication origin located in the lamin
B2 gene locus in a cell-cycle-modulated manner.
Here we report that activation of both the early-
firing lamin B2 and the late-firing hOrs8 human rep-
lication origins involves DNA topo II-dependent,
transient, site-specific dsDNA-break formation.
Topo IIb in complex with the DNA repair protein Ku
associates in vivo and in vitro with the pre-RC
region, introducing dsDNA breaks in a biphasic
manner, during early and mid-G1 phase. Inhibition
of topo II activity interferes with the pre-RC assem-
bly resulting in prolonged G1 phase. The data mech-
anistically link DNA topo IIb-dependent dsDNA
breaks and the components of the DNA repair
machinery with the initiation of DNA replication
and suggest an important role for DNA topology
in origin activation.
INTRODUCTION
Eukaryotic DNA replication is a stringently regulated and
remarkably precise multi-step process, ensuring the dupli-
cation of all chromosomes only once per cell cycle (1).
Replication is initiated at multiple origins scattered
along each chromosome, which are marked by the binding
of the evolutionarily conserved origin recognition complex
(ORC1-6). ORC acts as a cell-cycle-regulated landing
dock for the assembly of the pre-replicative complex
(pre-RC), which consists of ORC, Cdc6, Cdt1 and
the minichromosome maintenance protein complex
(MCM2–7), and its targeting onto chromatin is suﬃcient
to create a functional artiﬁcial mammalian replication
origin (2). However, unlike the Saccharomyces cerevisiae
ORC (ScORC), which recognizes the 11-bp ARS
consensus sequence, metazoan ORC exhibits low or no
preference for speciﬁc DNA sequences (3–5).
One of the basic features of DNA is the intertwining of
the DNA strands, which results in a global underwinding
of DNA (negatively supercoiled) in all species (6). This
underwinding facilitates sister DNA strand separation
and aﬀects accessibility of trans-acting factors to DNA
(7). The topological state of the DNA in the cell is being
managed by the DNA topoisomerases (8), which accom-
plish this by creating either a single-strand (type I subfam-
ily) or double-strand (type II subfamily) break in DNA,
thus permitting the rotation of one or two DNA strands,
respectively, around the DNA axis and relaxation of the
torsional stress. A role for topoisomerases in the initiation
step of DNA replication has been proposed, as they are
required for the activation of the simian virus 40 (SV40)
(9–12), bovine papilloma virus (BPV) (13) and Epstein-
Barr virus (EBV) replication origins (14). Furthermore,
it was shown that Drosophila melanogaster ORC
(DmORC) exhibits mild sequence speciﬁcity, but strong
preference for negatively supercoiled DNA, suggesting
that the topological state of the DNA is a critical fac-
tor for origin speciﬁcation in that organism (15).
Recently, topoisomerases I and II (topo I and II) were
also found to interact speciﬁcally with the human lamin
B2 replication origin in a cell-cycle-regulated manner,
indicating that the role of DNA topology during pre-RC
assembly may be applicable in mammalian genomes as
well (16,17).
The origin of DNA replication located at the 30 end of
the human gene for lamin B2 has been previously mapped
to the initiating nucleotide (18,19). It is an early-activated
origin, ﬁring in the ﬁrst minute of S phase (20), and is
active in a variety of cell types, including cells of myeloid,
epithelial, neuronal, ﬁbroblast origin and primary periph-
eral blood lymphocytes (21). Similarly, Ors8 has been
shown by electron microscopic studies as well as in situ
chromosomal and episomal replication assays to be a
replication origin in monkey and human cells (22–24).
However, unlike its monkey counterpart (mOrs8) which
is known to be early activated in monkey kidney (CV-1)
cells (25,26), the human homologue (hOrs8) replicates
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mOrs8 and hOrs8.
In this study, we describe the functional synergy of
the DNA topology and DNA repair machineries during
pre-RC assembly. We present evidence that Ku and topo
IIb directly interact with replication origins in vivo and
in vitro, and that their targeting onto chromatin during
G1 phase leads to topologic changes in the chromosomal
regions that correspond to the human replication origins
lamin B2 and hOrs8. The generation of two consecutive
topo II-dependent dsDNA breaks in proximity to or
within the area covered by the pre-RC complex, during
early- and mid-G1 phase, is concurrent with the pre-RC
formation. Pharmacological inhibition of topo II results
in the inhibition of pre-RC and the downstream pre-
Initiation Complex (pre-IC) assembly. The data suggest
that dynamic changes in the DNA structure occur
during pre-RC assembly and indicate that DNA topology
is a critical parameter aﬀecting the initiation of DNA
replication.
MATERIALS AND METHODS
Cell culture, cell-cycle analysis and drug treatments
HeLa cells were cultured in aMEM supplemented with
10% fetal bovine serum, penicillin (100mg/ml), streptomy-
cin (100mg/ml) and L-glutamine (1mmol/l) at 378C and
5% CO2. For M phase synchronization, cells were treated
with Nocodazole (100ng/ml) at 378C for 24h and sub-
jected to mitotic shake-oﬀ. For G1 phase synchronization,
cells were re-seeded and released from M-phase synchro-
nization into the cell cycle by the addition of pre-warmed
fresh complete medium. Treatments with the topo II
inhibitor merbarone (100mM) (Calbiochem) and the
DNA-PK inhibitor NU-7026 (10mM) (Calbiochem) were
performed for 1h at 378C. Cell-cycle progression was
monitored by FACS analysis using a Beckman
ﬂow cytometer.
Extract preparation, immunoblot analysis and
quantification
Nuclear cell extracts (NEs) were prepared as previously
described (27) and the protein concentration of each
extract preparation was determined using the Bradford
Protein Assay. Western blot analysis was carried out
according to standard protocols (28) using the antibodies
indicated in Supplementary Data.
Electrophoretic mobility-shift assay (EMSA)
Nuclear cell extracts (10mg) or 100ng of recombinant
Ku (TREVIGEN), Topo IIb (generous gift from Dr Neil
Osheroﬀ, Vanderbilt University Medical Center) and
14-3-3 proteins, were incubated with 0.4fmol of
32P-labeled PCR products corresponding to the 186-bp
core element of the hOrs8 origin of DNA replication, for
1h on ice. Binding to the oligonucleotide was performed
in the presence of high excess poly-dI dC (Amersham-
Pharmacia), used as non-speciﬁc competitor, and in a
ﬁnal volume of 20ml including binding buﬀer (10mM
Tris–HCl, pH 7.5, 80mM NaCl, 1mM EDTA, 10mM
b-mercaptoethanol, 0.1% Triton X-100, 4% glycerol).
The amount of poly-dI dC was optimized to allow detec-
tion of speciﬁc origin DNA-binding complexes in the
presence of excess free probe. The mixtures were subjected
to electrophoresis on a native 5% PAGE at 160V in 0.5 
TBE and the gels were then dried and subjected to auto-
radiography. For electrophoretic mobility-shift competi-
tion assays, increasing molar excess amounts of cold
probe were included in the reactions as indicated in the
ﬁgures. For the interference experiments the nuclear
extracts were pre-incubated with 1mg of anti-Ku80
(M-20), anti-TopoIIb (C-19), anti-ORC2 (H300) (Santa
Cruz Biotechnology, Santa Cruz, CA) or normal rabbit
serum in binding buﬀer for 1h at 48C followed by the
standard-binding reaction.
Chromatin immunoprecipitation assay (ChIP)
ChIP experiments were performed as previously described
(29). Brieﬂy, sheared chromatin lysates from 2 10
7 cells
were pre-cleared by incubation with Protein G or Protein
A agarose, and were subsequently incubated with 20mg
of anti-Ku80, anti-TopoIIb, anti-PARP-1, anti-ORC2,
anti-ORC4, anti-Cdt1, anti-Cdc45 or pre-immune serum.
Co-precipitated DNA was washed successively with Lysis
Buﬀer [50mM HEPES–KOH, pH 7.5, 140mM NaCl,
2mM EDTA, 1% Triton X-100, complete protease inhi-
bitors tablet (Roche Molecular Biochemicals)], WB1
(50mM Tris–HCl, pH 7.5, 500mM NaCl, 0.1% NP40,
0.05% sodium deoxycholate, complete protease inhibi-
tors), WB2 (50mM Tris–HCl, pH 7.5, 0.1% NP40,
0.05% sodium deoxycholate, complete protease inhibi-
tors) and TE, isolated and puriﬁed.
DNA-break labelling and ChIP
Detection of transient DNA strand break formation was
preformed as previously described (30), with slight mod-
iﬁcations. Brieﬂy, cells were ﬁxed with Streck Tissue
Fixative (STF, Streck Laboratories), which does not
cause any DNA damage (31), harvested, washed twice
with ice-cold PBS, once with buﬀer A [0.25% Triton
X-100, 10mM EDTA, 10mM HEPES (pH 6.5)] and
once with buﬀer B [200mM NaCl, 1mM EDTA, 10mM
HEPES (pH 6.5)], and permeabilized with buﬀer C
[100mM Tris–HCl (pH 7.4), 50mM EDTA, 1% Triton
X-100). Subsequently, the nuclei were sequentially washed
with ice-cold PBS, deionized water and 1  terminal deox-
ynucleotide transferase (TdT; Promega) reaction Buﬀer.
The DNA breaks were labeled with biotin-16-
deoxyuridine triphosphate (biotin-16-dUTP) using 50U
of TdT for 1h at 378C and residual biotin-dUTP was
washed away with Buﬀer D [100mM Tris–Cl (pH 7.4),
150mM NaCl]. Nuclei were reﬁxed and ChIP was per-
formed using an anti-biotin antibody (A1559; Sigma), as
described above.
Real-time PCR quantification of DNA
Immunoprecipitated DNA was quantiﬁed using the
LightCycler FastStart DNA Master SYBR Green I kit
(Roche Molecular Biochemicals) according to the
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The sequences and ampliﬁcation conditions for all primer
sets used are listed in Supplementary Table S1, while the
ampliﬁcation, melting and standard curves are shown in
Supplementary Figure S2.
Sequence analyses
DNA sequences of characterized replication origins
(20,23,32–37) were scanned for the presence of the 12-bp
mammalian topo II consensus sequence (38), using
the EMBOSS alignment tool (http://www.ebi.ac.uk/
Tools/emboss/align/index.html) of the European
Bioinformatics Institute (EBI), allowing no gaps.
RESULTS
Ku and topo IIb bind onto replication origins
Topo I and II were recently shown to bind onto the lamin
B2 replication origin in a cell-cycle-modulated manner
(16). Unlike topo I, however, although puriﬁed topo II
bound lamin B2 in a sequence-speciﬁc manner in vivo,i t
had no sequence preference in vitro, suggesting that it is
targeted to speciﬁc sites by another protein rather than by
direct enzyme/sequence recognition. A human origin bind-
ing activity, containing the Ku protein and topo II, was
previously puriﬁed through its ability to interact speciﬁ-
cally with the 186bp minimal functional sequence of the
monkey replication origin Ors8 and support its replica-
tion, prompting us to examine whether Ku might target
topo II onto replication origins. For this, we performed
EMSAs, using antisense oligonucleotides corresponding
to the 186-bp core of the human homologue of the
monkey Ors8 origin (hOrs8) (23). In the presence of
large excess of poly-dI dC, which blocks non-speciﬁc
and end-DNA binding, a predominant protein–DNA
complex was detected onto the replication origin
(Figure 1A, lane 2; indicated by an arrow). Oligonucleo-
tide competition experiments demonstrated greater
inhibition of complex formation in the presence of increas-
ing amounts of cold-speciﬁc (origin) oligonucleotide
(Figure 1A, lanes 3–5) compared to a non-speciﬁc oligo
of the same size and GC-content (Figure 1A, lanes 6–8),
indicating a speciﬁc interaction with the origin.
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Figure 1. Ku and topo IIb interact on the hOrs8 replication origin in vitro.( A) Representative EMSA showing the formation of a protein–DNA
complex (indicated by an arrow) formed on hOrs8 (lane 2) in the presence of high concentration of poly-di dC to block non-speciﬁc binding.
Addition of increasing amounts of origin probe (lanes 3–5) potently inhibits complex formation even at 10 -molar excess, unlike a non-speciﬁc oligo
(lanes 6–8) of the same size and GC content, which is less eﬀective. (B) Representative interference experiment showing the presence of Ku and
topo IIb in the complex, using anti-Ku80 (lane 5) and anti-topo IIb (lane 7) antibodies. An anti-ORC2 antibody (lane 6) and normal rabbit serum
(lane 2) were used as negative controls. (C) Representative EMSA using hOrs8 and recombinant Ku protein (lane 2), recombinant Ku and topo IIb
proteins (lane 5), or recombinant Ku and 14-3-3 proteins (lane 6). Additional controls, where Ku has been omitted from the reaction, but in the
presence of recombinant topo IIb (lane 3), 14-3-3 (lane 4), or both topo IIb and 14-3-3 (lane 7), are also shown. All experiments were performed in
triplicate giving rise to reproducible results.
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aﬃnity of the complex for the origin region is 6-fold
higher by comparison to the non-speciﬁc probe. We next
examined whether Ku and topo IIb are members of the
protein–DNA complex formed onto the origin, using anti-
bodies against the 80-kDa subunit of Ku (Ku80) and topo
IIb. As can be seen in Figure 1B, use of the anti-Ku80
(lane 5) and anti-topo IIb (lane 7) antibodies resulted in
the inhibition of the origin-speciﬁc complex, indicating the
presence of these proteins in it, whereas use of pre-immune
rabbit serum (lanes 2 and 4) or an antibody targeted
against ORC2 (lane 6) had no eﬀect on complex forma-
tion. Use of recombinant proteins showed that topo IIb is
targeted onto origin DNA in vitro by the Ku heterodimer
(Ku70/Ku80), reproducibly forming a complex of reduced
electrophoretic mobility (Figure 1C, lane 5) by compari-
son to that formed in the presence of Ku alone (Figure 1C,
lane 2). This was not found to be the case for the 14-3-3
protein, which has been shown to bind to cruciform struc-
tures at replication origins in vivo (39–41) (Ku does not
target 14-3-3 onto hOrs8, since the addition of 14-3-3 does
not aﬀect the mobility of the Ku/DNA complex—
compare lanes 2 and 6—nor does 14-3-3 target topo
IIb onto it; Figure 1C, lanes 6 and 7, respectively), or a
non-origin DNA region (data not shown), suggesting that
this targeting is both sequence- and protein-speciﬁc. The
in vivo association of Ku and topo IIb with the hOrs8 and
lamin B2 replication origins (origin maps are shown
in Figure 2A) was analyzed by ChIP assays, using anti-
Ku and anti-topo IIb antibodies (Figure 2B). Both pro-
teins were found to bind in vivo onto both of these origins
(Figure 2B, lanes 8 and 10), with some background
binding detected at the non-origin-containing chromo-
somal regions located 4kb and 2kb away from the
hOrs8 and lamin B2 origins, respectively (Figure 2B,
lanes 9 and 11). ORC2, which binds to both origins
(16,42), was used as a positive control (Figure 2B, lane 12).
In light of the recent ﬁnding that topo IIb, in complex
with Ku and PARP-1, participate in the recruitment of the
transcription machinery and activation of the pS2 gene,
by modifying the chromatin architecture of its promoter
(30), we examined whether PARP-1 is also present in the
origin-speciﬁc protein complex. Indeed, PARP-1 was
found to associate with the lamin B2 and hOrs8 origins
(Figure 2B, lane 14), similarly to ORC2, Ku and topo IIb.
The origin association of these proteins was also ana-
lyzed as a function of the cell cycle (Figure 3). For this,
cells were synchronized in M phase, using mitotic shake-
oﬀ, and then released into G1 phase by the addition of
complete media. Upon this treatment, cells started enter-
ing G1 phase after 2h and reached S phase at 10h, as
monitored by FACS analysis (Figure 3A) and the levels
of the G2/M, G1 and S phase Cyclins B, E and A, respec-
tively (Figure 3B). All three proteins (Ku, topo IIb and
PARP-1) bound to the lamin B2 and hOrs8 origins during
early and mid-G1 phase, while they dissociated upon
cell entry into S phase, following the same pattern
(Figure 3C). The expression levels of these proteins
during G1 phase were constant (Figure 3B), suggesting
that their origin-association pattern is solely due to
their chromatin recruitment. Furthermore, all proteins
co-precipitated in pull-down experiments (Figure 3D),
indicating that they either associate with replication
origins in close proximity to one another or they function
hOrs8
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Figure 2. Ku, topo IIb and PARP-1 bind onto replication origins in vivo.( A) Maps of the hOrs8 (i) and lamin B2 (ii) origin loci and the primers
corresponding to the origin-containing (hOrs8 and LB2, respectively), origin-ﬂanking (Sets 1 and 2) and origin-lacking (hOrs8+2kb and LB2C,
respectively) amplicons. The location of the amplicons relative to the gene exons as well as their distance in kb is indicated. (B) ChIP assay using
anti-Ku80, -topo IIb and -PARP-1 antibodies. The amount of DNA immunoprecipitated corresponding to the hOrs8 and lamin B2 origin-containing
(O) and their respective origin-lacking control (C) regions, is shown. Immunoprecipitation with normal rabbit serum (NRS) and an anti-NF-kB
antibody were used as negative controls, while ORC2, previously known to bind to both origins, was used as a positive control. A sample with water
as template (dH2O) was used as a negative control for the real-time PCR reaction, whereas a sample with genomic DNA as template (gDNA) was
used as positive control.
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Figure 3. Origin association of the Ku, topo IIb and PARP-1 complex during G1 phase. (A) Cell-cycle progression following release from M phase.
Cell-cycle distribution of asynchronous, M phase-synchronized and M phase-released cells was monitored by FACS analysis. Synchronization of cells
in M phase was done using nocodazole treatment and mitotic shake and hourly samples were taken for 11h after their release from M phase.
(B) Representative western blot analysis, showing the levels of the M phase-speciﬁc Cyclin B, G1 phase-speciﬁc Cyclin E and S phase-speciﬁc
Cyclin A following release from M phase. The protein levels of Ku80, topo IIb and PARP-1 showing constant expression during G1 phase are also
shown. ORC2, known to be stably expressed throughout the cell cycle, was used as the loading control. (C) ChIP assay showing an analysis of the
association of Ku80, topo IIb and PARP-1 with hOrs8 (i) and lamin B2 (ii) as a function of the cell cycle. Abundance of the origin-containing or
origin-lacking regions in the Ku80, topo IIb and PARP-1 immunoprecipitates at the indicated timepoints following release from M phase. Values are
expressed as molecules of immunoprecipitated DNA per 2 10
7 cells and represent the average of three experiments and 1 SD. The horizontal bar
represents background DNA immunoprecipitated by NRS. (D) Reciprocal pull-down experiment using anti-Ku80, -topo IIb and -PARP-1, -ORC2
antibodies and NRS (negative control), and immunostaining with the same antibodies. Nuclear extracts (NEs) corresponding to 10% of the input
protein used in the co-immunoprecipitation reaction, were used as positive control in the western blot analysis (lane 2).
5718 Nucleic Acids Research, 2009, Vol. 37,No. 17as a holocomplex, similar to their role in transcription
activation (30).
Topo-II-mediated, transient dsDNA breaks
during G1 phase
We next examined whether the enzymatic activity of topo
IIb might alter the DNA topology at replication origins
during pre-RC assembly. DNA-break formation was
screened, using a recently developed protocol that detects
DNA-break formation at speciﬁc chromosomal loci by
combining biotin-dUTP labelling by TdT and subsequent
ChIP analysis, using an anti-biotin antibody (see
‘Materials and Methods’ section, Figure 4A). In HeLa
cells traversing through G1 phase, putative DNA breaks
were detected in both the lamin B2 and hOrs8 replication
origins (Figure 4B), but no enrichment of biotin incorpo-
ration was observed at the non-origin containing chromo-
somal regions located 4kb and 2kb away, respectively, as
evidenced by the background levels of the corresponding
amplicons (data not shown). Time-course DNA-break
labelling indicated that the origin-speciﬁc DNA breaks
occurred in a biphasic and dynamic fashion. An initial
break was detected early in G1 phase (within 4h upon
release) followed by a second one during mid-G1 phase
(within 7h post-release). Generation of both breaks was
transient, as they started reverting to their initial status
within 1h. Interestingly, both breaks at the hOrs8 origin
occurred within the origin core (Figure 4Bi), whereas in
the lamin B2 origin only one break was created within the
area covered by the pre-RC complex (Figure 4Bii).
Consistent with this ﬁnding is the presence of a topo II
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Figure 4. DNA-break formation during G1 phase. (A) Schematic diagram explaining the three diﬀerent scenarios of the DNA-break labelling assay.
No break formation (left) should lead to background levels of DNA immunoprecipitated by the anti-biotin antibody. In the case of a break in
proximity to the origin, but outside of the core region (middle), increased amounts of the PCR products upstream (Set 1), downstream (Set 2) and
ﬂanking (Ori) the origin region should be produced, while an intra-origin break (right) should result in increased Set 1 and Set 2, but decreased Ori
products. (B) Generation of putative DNA breaks in hOrs8 (i) and lamin B2 (ii) during G1 phase. Encircled are the two consecutive DNA breaks
formed at the two chromosomal loci, two intra-origin breaks in hOrs8, and one inter-origin and one intra-origin in lamin B2. Values are expressed as
ratios of the individual DNA abundances at each timepoint to the maximal abundance observed during the course of the assay, following normal-
ization with the non-origin containing regions. Error bars represent 1 SD of three separate experiments. (C) Eﬀect of merbarone on DNA-break
formation at the hOrs8 (i) and lamin B2 (ii) replication origins. Error bars represent 1 SD of three separate experiments. (D) DNA-break labelling
assay at the hOrs8 (i) and lamin B2 (ii) replication origins following NU-7026 treatment. Error bars represent 1 SD of three separate experiments.
Nucleic Acids Research, 2009,Vol.37, No. 17 5719site upstream of the pre-RC area at the lamin B2 origin,
which might correspond to a scaﬀold attachment region
(16). To ascertain whether the origin DNA cleavages are
indeed topo-II mediated, the time-course DNA-break
labelling assay was repeated in the presence of the topo
II inhibitor, merbarone (5-N-phenylcarboxamido-2-
-thiobarbituric acid), which inhibits the enzyme’s cleaving
activity without damaging the DNA or stabilizing inter-
mediate DNA-topo II cleavable complexes (as per manu-
facturer’s speciﬁcations). The advantage of topo II
pharmacological inhibition over an RNAi approach is
the ability to add the inhibitor after cell exit from G2/M,
when topo II is known to participate in chromosome con-
densation and segregation, thus focusing on its role in G1
phase. Treatment with merbarone prevented the DNA
breaks at the hOrs8 (Figure 4Ci), and lamin
B2 (Figure 4Cii) origins, indicating that they represent
transient double-stranded DNA (dsDNA) breaks trig-
gered by DNA topo II.
In light of the presence of Ku, the binding subunit of
DNA-PK, at the origin area, we also examined the eﬀect
of the inhibition of the DNA-PK enzymatic activity,
using the DNA-PK inhibitor NU-7026. In contrast to
merbarone, NU-7026 had no eﬀect on DNA-break forma-
tion at either of the two orgins (Figure 4D), suggesting
either that Ku only functions in tethering topo IIb onto
them, or that the DNA-PK activity is only activated under
stress conditions.
Functional significance of DNA-break formation
In view of the presence of topo IIb in close proximity to
the DNA replication start site, which suggested a role in
the initiation step of DNA replication, we examined the
eﬀect of topo II inhibition on pre-RC assembly. Using
ChIP assays, we analyzed the kinetics of recruitment of
the pre-RC members at the hOrs8 and lamin B2 replica-
tion origins during G1 phase. Pre-RC is known to assem-
ble onto replication origins in a stepwise manner (Sclafani
and Holzen); origins are initially marked by the ORC
hexamer, which is recognized and bound by Cdc6 and
Cdt1 during G1-phase. Binding of the latter two proteins
permits the subsequent loading of the putative DNA
helicase, the MCM2–7, which becomes active by forming
a complex with Cdc45 and GINS (43). Consistent with
this, the hOrs8 (Figure 5B; black bars) and lamin B2
(Figure 5C; black bars) origins were initially bound by
ORC2 (2h upon release from M phase; Figure 5Bi and
Ci, black bars), followed by ORC4 (4h upon release from
M phase; Figure 5Bii and Cii, black bars), Cdt1 (4h upon
release from M phase; Figure 5Biii and Ciii, black bars)
and ﬁnally Cdc45 (7h upon release from M phase;
Figure 5Biv and Civ, black bars). The expression levels
of these proteins during G1 phase were constant
(Figure 5A), suggesting that their origin-association
pattern is due to their stepwise recruitment. Treatment
with merbarone blocked recruitment of ORC4 (4h
upon release from M phase; Figure 5Bii, compare corre-
sponding grey and black bar), Cdt1 (4h and 7h upon
release from M phase; Figure 5Biii, compare correspond-
ing grey and black bars) and Cdc45 (7h upon release from
M phase; Figure 5Biv, compare corresponding grey and
black bar) at the hOrs8 replication origin, whereas ORC2
binding was not aﬀected (Figure 5Bi; grey bars). Similarly,
inhibition of dsDNA-break formation led to impaired
recruitment of ORC4, Cdt1 and Cdc45, but not of
ORC2, onto the lamin B2 origin (Figure 5Cii, iii, iv and
i, respectively; grey bars). This is in agreement with previ-
ous studies, showing that Ku participates in the stepwise
pre-RC assembly at a stage downstream of ORC2 (42,44).
Furthermore, merbarone treatment resulted in prolonged
G1 phase (Supplementary Figure S1) supporting the
notion that pre-RC assembly was aﬀected by topo II activ-
ity. Overall, these results suggest that dynamic changes in
the DNA topology of origin-containing chromosomal
regions naturally occur during pre-RC assembly and
that topo II activity is required for replication initiation.
DISCUSSION
High order chromatin organization is believed to play an
important role in metazoan DNA replication origin spec-
iﬁcation and selection (5,45). Previous studies implicated
chromatin topology in the initiation step of replication of
viral and D. melanogaster genomes (9,11–15,46). In this
study, we examined whether this role is extended to the
human genome as well. Our ﬁndings indicate that activa-
tion of the human lamin B2 and hOrs8 replication origins
involves the generation of topo-II-dependent transient
dsDNA breaks, which occur in a biphasic manner,
during early- and mid-G1 phase. However, although
both breaks at the hOrs8 replication origin occurred
within the origin core, in the lamin B2 origin only
one break was created within the area covered by the
pre-RC complex and the other one occurred in close prox-
imity to, but outside the origin region. It will be interesting
to determine whether this is associated with the diﬀerential
activation timing of the two origins, lamin B2 being early-
ﬁring (20) and hOrs8 being late-ﬁring (23). Mammalian
cells possess two isoforms of topo II, a and b, with high
sequence homology (68% identity and 86% similarity)
(47,48). Topo IIa levels ﬂuctuate during the cell-cycle
peaking in G2/M (49,50) and thus appears to be required
for chromosome condensation and segregation, whereas
topo IIb is less well understood (51). Recently, it was
reported that the topo IIb isoform is implicated in the
initiation of DNA replication of KSHV, which utilizes
the host molecular machinery in order to proliferate
(52). In agreement, we found that topo IIb binds onto
human replication origins, suggesting a DNA replica-
tion-speciﬁc role for this isoform.
Targeting of topo IIb onto chromatin is dependent on
complex formation with the Ku protein, the DNA-binding
subunit of DNA-PK, which has been previously linked to
the initiation step of DNA replication (29,42,44,53).
PARP-1, a multi-functional protein involved in chromatin
regulation, transcription regulation, DNA repair and cell
death (54), was also found to be a member of this com-
plex. These proteins were previously shown to form
an activation complex on the promoter of the pS2 gene
participating in local changes of chromatin architecture
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estradiol-dependent transcriptional activation (30,55).
Similarly, a topo IIb/Ku/PARP-1 holoenzyme seems to
act in origin ﬁring, binding onto replication origins
during G1 phase and regulating the chromatin topology
of the surrounding chromosomal region.
Although the best characterized DNA-binding activity
of Ku is its DNA-end-binding activity (56,57), a number
of studies, using closed DNA minicircles or plasmids that
lack free ends, have shown that Ku also exhibits sequence-
speciﬁc DNA binding, binding to regulatory DNA
elements and aﬀecting gene transcription and DNA
replication (58,59). In vivo studies have also supported
the binding of Ku to speciﬁc regulatory elements
(29,30,60–63). In this study, excess amounts of the non-
speciﬁc competitor poly-dI dC were used, as a source of
free DNA-ends in order to compete out Ku’s aﬃnity for
DNA-ends and reveal origin DNA-speciﬁc complex for-
mation. Although resolution of the crystal structure of the
Ku heterodimer on DNA showed that it has a preformed
ring that encircles duplex DNA making no contacts with
DNA bases (64), a number of mechanisms can be specu-
lated for Ku’s recognition of speciﬁc internal sequences,
including the dimerization of Ku upon recognition of spe-
ciﬁc sequences, as well as the extrusion of speciﬁc internal
sequences to hairpins or cruciforms, which are then recog-
nized by Ku. In support of these scenarios, the SAP
domain of the Ku70 carboxyterminus has been proposed
to be able to recognize speciﬁc DNA sequences (64,65),
whereas the Ku heterodimer has been shown to have
aﬃnity for DNA secondary structures (66).
Pharmacological inhibition of the topo II activity by the
speciﬁc inhibitor merbarone, resulted in suppression of
DNA-break formation and blocked the pre-RC assembly
as well as the downstream initiator protein Cdc45. In
contrast, DNA-PK inhibition had no eﬀect on DNA-
break formation suggesting that Ku functions in tethering
topo IIb onto replication origins. This would increase the
sequence speciﬁcity of topo IIb cleavage, in a manner
similar to that shown for RAG recombinases, which
have similar enzymatic properties to DNA topoisomerases
(67). Alternatively, DNA-PK activity may be involved
in dsDNA-break repair under conditions of topo II
malfunction, acting as a backup mechanism to ensure
chromosomal stability. Interestingly, pre-RC formation
was blocked at two stages, upstream of ORC4 and
Cdt1 recruitment, respectively. In contrast, origin-binding
by ORC2 remained unaﬀected, suggesting that topo
II participates in pre-RC assembly rather than origin
recognition. This is in agreement with previous studies
showing that Ku participates in the stepwise pre-RC
assembly at a stage downstream of ORC2 (42,44).
ORC2 targeting may instead be attributed to other acces-
sory factors with intrinsic DNA sequence speciﬁcity,
such as AIF-C (68), Trf2 (69), EBNA-1 (70), HMGA1a
(71) or topo I (16).
Overall, the data support the notion that topo IIb
activity is required for the initiation of DNA replica-
tion, at least at the lamin B2 and hOrs8 replication
origins studied here. Sequence analysis of eight well-
characterized human replication origins identiﬁed the
presence of the mammalian topo II consensus sequence
(Table 1), suggesting that the mechanism shown here
may be more generalized and applicable genome-wide,
as well as underscoring the importance of DNA topology
as an important parameter that is crucial for mammalian
origin activation.
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